Clinical Trial Update: Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

View source ↗

Summary

An update on a Japanese registry evaluating rivaroxaban's effectiveness and safety for preventing recurrence of deep vein thrombosis and pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Nihon University | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Status: UNKNOWN